玫瑰痤疮病情评价标准研究进展

doi:10.35541/cjd.20210581

中华皮肤科杂志 ›› 2024, Vol. 57 ›› Issue (2): 182-185.doi: 10.35541/cjd.20210581

玫瑰痤疮病情评价标准研究进展

张悦陶梦李敏姜沛彧刘韵祎刘乙萱潘婼芯许阳

南京医科大学第一附属医院皮肤科，南京 210029

收稿日期:2021-08-11 修回日期:2022-03-20 发布日期:2024-02-01
通讯作者: 许阳 E-mail:cardioos@163.com
基金资助:
国家自然科学基金（81301384）

Severity assessment criteria for rosacea

Zhang Yue, Tao Meng, Li Min, Jiang Peiyu, Liu Yunyi, Liu Yixuan, Pan Ruoxin, Xu Yang

Department of Dermatology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

Received:2021-08-11 Revised:2022-03-20 Published:2024-02-01
Contact: Xu Yang E-mail:cardioos@163.com
Supported by:
National Natural Science Foundation of China（81301384）

摘要/Abstract

摘要： 【摘要】玫瑰痤疮是一种慢性复发性炎症性皮肤病，对其临床症状及严重程度的正确评估有助于治疗方案的选择。因此，本文综述目前用于玫瑰痤疮病情评价的主观、半主观以及客观方法，为临床评价玫瑰痤疮严重程度提供有用工具，并为临床上依据疗效调整治疗方案提供参考。

关键词: 红斑痤疮, 疾病严重程度指数, 病情评价标准

Abstract: 【Abstract】 Rosacea is a chronic recurrent inflammatory skin disease, and correct assessment of clinical symptoms and severity facilitates treatment options. This review summarizes a range of subjective, semi-subjective and objective methods currently used in the assessment of rosacea severity, in order to provide useful tools for clinical assessment of rosacea severity and give guidance on treatment modification according to the therapeutic effect.

Key words: Rosacea, Severity of illness index, Severity assessment criteria

张悦陶梦李敏姜沛彧刘韵祎刘乙萱潘婼芯许阳. 玫瑰痤疮病情评价标准研究进展[J]. 中华皮肤科杂志, 2024,57(2):182-185. doi:10.35541/cjd.20210581

Zhang Yue, Tao Meng, Li Min, Jiang Peiyu, Liu Yunyi, Liu Yixuan, Pan Ruoxin, Xu Yang. Severity assessment criteria for rosacea[J]. Chinese Journal of Dermatology, 2024, 57(2): 182-185.doi:10.35541/cjd.20210581

参考文献 36

［1］	Wilkin J, Dahl M, Detmar M, et al. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea［J］. J Am Acad Dermatol, 2004,50（6）:907⁃912. doi: 10.1016/j.jaad.2004. 01.048.
［2］	中华医学会皮肤性病学分会玫瑰痤疮研究中心, 中国医师协会皮肤科医师分会玫瑰痤疮专业委员会. 中国玫瑰痤疮诊疗指南（2021版）［J］. 中华皮肤科杂志, 2021, 54（4）: 279⁃288. doi: 10.35541/cjd.20201078.
［3］	Tan J, Almeida LM, Bewley A, et al. Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus （ROSCO） panel［J］. Br J Dermatol, 2017,176（2）:431⁃438. doi: 10.1111/bjd.15122.
［4］	Kwon HH, Jung JY, Lee WY, et al. Combined treatment of recalcitrant papulopustular rosacea involving pulsed dye laser and fractional microneedling radiofrequency with low⁃dose isotretinoin［J］. J Cosmet Dermatol, 2020,19（1）:105⁃111. doi: 10.1111/jocd.12982.
［5］	Kawata AK, Revicki DA, Thakkar R, et al. Flushing ASsessment Tool （FAST）: psychometric properties of a new measure assessing flushing symptoms and clinical impact of niacin therapy［J］. Clin Drug Investig, 2009,29（4）:215⁃229. doi: 10. 2165/00044011⁃200929040⁃00001.
［6］	Parson HK, Harati H, Cooper D, et al. Role of prostaglandin D2 and the autonomic nervous system in niacin⁃induced flushing［J］. J Diabetes, 2013,5（1）:59⁃67. doi: 10.1111/j.1753⁃0407. 2012.00216.x.
［7］	Norquist JM, Watson DJ, Yu Q, et al. Validation of a questionnaire to assess niacin⁃induced cutaneous flushing［J］. Curr Med Res Opin, 2007,23（7）:1549⁃1560. doi: 10.1185/030079907x199637.
［8］	Banka SS, Thachil R, Levine A, et al. Randomized controlled trial of different aspirin regimens for reduction of niacin⁃induced flushing［J］. Am J Health Syst Pharm, 2017,74（12）:898⁃903. doi: 10.2146/ajhp160219.
［9］	Tan J, Liu H, Leyden JJ, et al. Reliability of clinician erythema assessment grading scale［J］. J Am Acad Dermatol, 2014,71（4）:760⁃763. doi: 10.1016/j.jaad.2014.05.044.
［10］	张二佳, 林彤. 两种强脉冲光治疗玫瑰痤疮的疗效观察［J］. 中华皮肤科杂志, 2021,54（3）:207⁃211. doi: 10.35541/cjd. 20200621.
［11］	Pietschke K, Schaller M. Long⁃term management of distinct facial flushing and persistent erythema of rosacea by treatment with carvedilol［J］. J Dermatolog Treat, 2018,29（3）:310⁃313. doi: 10.1080/09546634.2017.1360991.
［12］	Tong LX, Moore AY. Brimonidine tartrate for the treatment of facial flushing and erythema in rosacea［J］. Expert Rev Clin Pharmacol, 2014,7（5）:567⁃577. doi: 10.1586/17512433.2014. 945910.
［13］	Layton AM, Schaller M, Homey B, et al. Brimonidine gel 0.33% rapidly improves patient⁃reported outcomes by controlling facial erythema of rosacea: a randomized, double⁃blind, vehicle⁃controlled study［J］. J Eur Acad Dermatol Venereol, 2015,29（12）:2405⁃2410. doi: 10.1111/jdv.13305.
［14］	施琦, 赵志祥, 谢红付, 等. 玫瑰痤疮患者阵发性潮红的临床特征分析及对生活质量的影响［J］. 中华皮肤科杂志, 2020,53（5）:340⁃344. doi: 10.35541/cjd.20191198.
［15］	Staedtler G, Shakery K, Endrikat J, et al. An empirically generated responder definition for rosacea treatment［J］. Clin Cosmet Investig Dermatol, 2017,10:347⁃352. doi: 10.2147/CCID.S139352.
［16］	Schaller M, Gonser L, Belge K, et al. Dual anti⁃inflammatory and anti⁃parasitic action of topical ivermectin 1% in papulopustular rosacea［J］. J Eur Acad Dermatol Venereol, 2017,31（11）:1907⁃1911. doi: 10.1111/jdv.14437.
［17］	Trave I, Merlo G, Cozzani E, et al. Real⁃life experience on effectiveness and tolerability of topical ivermectin in papulopustular rosacea and antiparasitic effect on Demodex mites［J］. Dermatol Ther, 2019,32（6）:e13093. doi: 10.1111/dth.13093.
［18］	Webster G, Schaller M, Tan J, et al. Defining treatment success in rosacea as ′clear′; may provide multiple patient benefits: results of a pooled analysis［J］. J Dermatolog Treat, 2017,28（5）:469⁃474. doi: 10.1080/09546634.2017.1343435.
［19］	Moustafa F, Lewallen RS, Feldman SR. The psychological impact of rosacea and the influence of current management options［J］. J Am Acad Dermatol, 2014,71（5）:973⁃980. doi: 10.1016/j.jaad. 2014.05.036.
［20］	Deng Y, Peng Q, Yang S, et al. The Rosacea⁃specific Quality⁃of⁃Life instrument （RosQol）: revision and validation among Chinese patients［J］. PLoS One, 2018,13（2）:e0192487. doi: 10.1371/journal.pone.0192487.
［21］	Antony MM, Bieling PJ, Cox BJ, et al. Psychometric properties of the 42⁃item and 21⁃item versions of the Depression Anxiety Stress Scales in clinical groups and a community sample［J］. 1998, 10（2）: 176⁃181.
［22］	Yilmaz AE, Gençöz T, Wells A. Psychometric characteristics of the Penn State Worry Questionnaire and Metacognitions Questionnaire⁃30 and metacognitive predictors of worry and obsessive⁃compulsive symptoms in a Turkish sample［J］. Clin Psychol Psychother, 2008,15（6）:424⁃439. doi: 10.1002/cpp.589.
［23］	Johnco C, Wuthrich VM, Brenes GA, et al. Evidence⁃based assessment of treatment outcomes for late⁃life generalized anxiety disorder using the Penn State Worry Questionnaire （PSWQ） and Penn State Worry Questionnaire ⁃ Abbreviated （PSWQ⁃A）［J］. Int Psychogeriatr, 2021:1⁃13. doi: 10.1017/S1041610221000351.
［24］	Ding DM, Tu Y, Man MQ, et al. Association between lactic acid sting test scores, self⁃assessed sensitive skin scores and biophysical properties in Chinese females［J］. Int J Cosmet Sci, 2019,41（4）:398⁃404. doi: 10.1111/ics.12550.
［25］	Zhang H, Tang K, Wang Y, et al. Rosacea treatment: review and update［J］. Dermatol Ther （Heidelb）, 2021,11（1）:13⁃24. doi: 10.1007/s13555⁃020⁃00461⁃0.
［26］	Darlenski R, Kazandjieva J, Fluhr JW, et al. Lactic acid sting test does not differentiate between facial and generalized skin functional impairment in sensitive skin in atopic dermatitis and rosacea［J］. J Dermatol Sci, 2014,76（2）:151⁃153. doi: 10.1016/j.jdermsci.2014.08.014.
［27］	Glas B, Claeson AS. Skin sensitivity to capsaicin, perceived stress and burn out among patients with building⁃related symptoms［J］. Int Arch Occup Environ Health, 2021,94（5）:791⁃797. doi: 10.1007/s00420⁃020⁃01647⁃x.
［28］	Agner T, Serup J. Quantification of the DMSO⁃response⁃⁃a test for assessment of sensitive skin［J］. Clin Exp Dermatol, 1989,14（3）:214⁃217. doi: 10.1111/j.1365⁃2230.1989.tb00935.x.
［29］	Chen SY, Wang XM, Liu YQ, et al. Dimethyl sulfoxide could be a useful probe to evaluate unusual skin angioneurotic reaction and epidermal permeability［J］. Cutan Ocul Toxicol, 2014,33（1）:63⁃69. doi: 10.3109/15569527.2013.821615.
［30］	Ma Y, Li L, Chen J, et al. Distinguishing rosacea from sensitive skin by reflectance confocal microscopy［J］. Skin Res Technol, 2020,26（5）:671⁃674. doi: 10.1111/srt.12851.
［31］	Lallas A, Argenziano G, Longo C, et al. Polygonal vessels of rosacea are highlighted by dermoscopy［J］. Int J Dermatol, 2014,53（5）:e325⁃e327. doi: 10.1111/ijd.12270.
［32］	Sun Y, Chen L, Zhang Y, et al. Topical photodynamic therapy with 5⁃aminolevulinic acid in Chinese patients with rosacea［J］. J Cosmet Laser Ther, 2019,21（4）:196⁃200. doi: 10.1080/14764172.2018.1502455.
［33］	Wang XY, Liu YY, Liu YX, et al. A predictive model for differential diagnosis between rosacea and sensitive skin: a cross⁃sectional study［J］. Chin Med J （Engl）, 2020,133（17）:2132⁃2134. doi: 10.1097/CM9.0000000000001001.
［34］	Gao Y, Lin W, Zhou S, et al. Treatment of rosacea using acupuncture for improving the local skin microcirculation: a case report［J］. Medicine （Baltimore）, 2018,97（34）:e11931. doi: 10.1097/MD.0000000000011931.
［35］	Bustos R, Cortes A, McNab ME, et al. Color doppler ultrasonographic evaluation of management of papulopustular rosacea［J］. J Am Acad Dermatol, 2021,84（5）:1434⁃1437. doi: 10.1016/j.jaad.2020.06.068.
［36］	Choi JE, Di Nardo A. Skin neurogenic inflammation［J］. Semin Immunopathol, 2018,40（3）:249⁃259. doi: 10.1007/s00281⁃018⁃0675⁃z.

[1]	潘婼芯顾多多张悦李敏陶梦许阳. 代谢组学在玫瑰痤疮研究中的应用进展[J]. 中华皮肤科杂志, 2024, 57(2): 178-181.
[2]	魏子妤杨勇. 离子通道与玫瑰痤疮发病机制的研究进展[J]. 中华皮肤科杂志, 2024, 57(2): 174-177.
[3]	刘亭微孟潇琦顾多多潘婼芯张悦许阳. 玫瑰痤疮发病机制的研究进展[J]. 中华皮肤科杂志, 2024, 57(2): 186-190.
[4]	李吉谢红付. 如何避免玫瑰痤疮的误诊[J]. 中华皮肤科杂志, 2024, 57(2): 119-122.
[5]	蒋献宋德宇. [开放获取] 从心身医学视角认识玫瑰痤疮[J]. 中华皮肤科杂志, 2024, 57(2): 123-126.
[6]	那君李若瑜仲少敏杨莉吴艳. 玫瑰痤疮真实世界诊疗现状调查分析[J]. 中华皮肤科杂志, 2024, 57(2): 127-133.
[7]	马光荣谢红付刘家双周钟莲周淞麒黄莹雪李吉. 玫瑰痤疮患者小肠细菌过度生长情况调查及临床特征分析[J]. 中华皮肤科杂志, 2024, 57(2): 134-140.
[8]	张晓东汪蔓雅朱英杰骆天德刘小明. 荧光染色法在面部皮肤蠕形螨检查中的应用评估[J]. 中华皮肤科杂志, 2023, 56(8): 766-769.
[9]	陶梦李敏刘乙萱刘韵祎姜沛彧张嘉文南宇晴许阳. 玫瑰痤疮与精神神经性疾病相关性研究进展[J]. 中华皮肤科杂志, 2023, 56(7): 693-697.
[10]	米淑宏余艳琴郝金奇李薇张杨贾喜梅黄毓娴孙怀玉石继海. 丘疹脓疱型玫瑰痤疮患者皮肤高频超声联合彩色多普勒血流成像的特征[J]. 中华皮肤科杂志, 2023, 56(6): 540-544.
[11]	李嘉祺叶枫鞠强. 表皮葡萄球菌共生性稳态与皮肤疾病[J]. 中华皮肤科杂志, 2023, 56(5): 459-462.
[12]	李容张家安陈崑. 玫瑰痤疮光电疗法研究进展[J]. 中华皮肤科杂志, 2023, 56(5): 468-470.
[13]	王小燕张嘉文刘韵祎刘乙萱姜沛彧李敏陶梦许阳. 玫瑰痤疮的皮肤影像学和无创检测技术相关进展[J]. 中华皮肤科杂志, 2023, 56(4): 361-364.
[14]	孙静徐英男林彤薛劲松. 重度玫瑰痤疮眼型28例眼部损害临床治疗结局分析[J]. 中华皮肤科杂志, 2023, 56(2): 142-145.
[15]	陈良宏孙艳王敬玉吴严. 本维莫德在皮肤病中的研究进展[J]. 中华皮肤科杂志, 2023, 0(2): 20210875-e20210875.

玫瑰痤疮病情评价标准研究进展

Severity assessment criteria for rosacea

PDF

PDF (Mobile)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 36

相关文章 15

Metrics

本文评价

推荐阅读 10